Hospitals in 3 states struggle to return online post-cyberattack

The latest stories trending on MedCity News.

Editor's Pick

Top Story Hospitals Still Struggling to Get Back Online 4 Days After Cyberattack on Prospect Medical Holdings Hospitals and outpatient treatment centers in at least three states are struggling to get their systems back online following a ransomware attack waged last week against parent company Prospect Medical Holdings. Some of these facilities have partially or completely halted patient care. Sponsored Content How To Improve Poor Data Quality Across the Healthcare Ecosystem and Make Workflows More Manageable Presented by IMO Health and MedCity News Join us on August 24th as we will explore the impact of poor data quality and methods to improve patient data quality. It will also highlight healthcare industry employee burnout and how to improve retention. Sign up today to join the event! Fireside Chat at INVEST Digital Health Don't miss this exciting and exclusive opportunity with Beth Andrews, Chief Digital Health Officer, Life Sciences & Healthcare, Dell Technologies | Global Alliances. Join us on October 26th at Pegasus Park in Dallas. Hurry, you can still save $150 until 8/25. Register Now

Featured News

Novel Social Anxiety Disorder Drug's Data Relieve Stress on a Beleaguered Biotech Vistagen Therapeutics' fast-acting nasal spray drug, fasedienol, hit primary and secondary goals of an abbreviated late-stage study in social anxiety disorder. Vistagen's stock price rocketed skyward on the results, which support progression to another Phase 3 study. Report: Fewer Adults Are Interested in Weight Loss Drugs If Not Covered by Insurance About half of adults, or 45%, said they are at least somewhat interested in taking a "safe, effective weight-loss drug," according to a new survey by KFF. However, just 16% of adults are still interested in taking weight-loss drugs if they're not covered by insurance. How Did The 3 Biggest For-Profit Hospital Chains Perform in Q2? HCA and Tenet reported net incomes for the second quarter, while CHS posted a net loss. All three health systems found themselves in a better financial position in Q2 2023 than they were in Q2 of last year, driven in large part by declining contract labor expenses. Talkiatry, NOCD Strike Partnership To Support Patients With OCD Talkiatry and NOCD are teaming up to improve care for patients with obsessive-compulsive disorder. Talkiatry specializes in medication management, while NOCD specializes in Exposure and Response Prevention therapy. Astellas Drug Acquired in $5.9B Deal Wins FDA Approval in Vision-Loss Disorder Izervay, a drug developed by Astellas Pharma subsidiary Iveric Bio, is now the second approved therapy for the degenerative vision-loss disorder geographic atrophy. The regulatory decision comes as safety concerns emerge around the first therapy for the disease, an Apellis Pharmaceuticals product. The Evolution of Patient-Centered Clinical Trial Design Clinical trial design will be one of the topics discussed at the upcoming INVEST Digital Health conference in Dallas on October 26. THREAD Clinical Trial Design Director Noah Goodson highlighted some of the milestones the sector has seen in recent years.

Resources

MedCity Moves Podcast: Recent Hires, Layoffs & an Interview with Leslie Orne, CEO of Trinity Life Sciences In this podcast we are joined by Leslie Orne, who just became the new CEO of Trinity Life Sciences. Her company provides consulting services and technology solutions to life sciences firms looking to commercialize their product.  Learn what Orne thinks is in store for AI innovation in the life sciences space. Listen Now

MedCity News • PO Box 901 • New York, NY unsubscribe